Orchestra 
DIGITAL WORLD
BRICS+ Media Centre 
MODERN RUSSIAN 
Belarusian and Chinese scientists develop nanoparticles for targeted cancer therapy
Breakthrough study highlights potential of ultrasound-activated treatment and immune response stimulation
Researchers from Belarus and China have announced the successful development of innovative polymer-based nanoparticles designed for advanced cancer treatment, reports BelTA, a partner of TV BRICS.
The joint research project, conducted by specialists from Belarus’ National Academy of Sciences and their Chinese counterparts in Shanghai, focused on the creation and testing of nanoparticles for use in sonodynamic therapy – a cutting-edge method that combines ultrasound technology with targeted drug delivery.
According to the research findings, the newly engineered nanoparticles demonstrated the ability to selectively accumulate in tumour cells when introduced into the body.
In addition to their direct therapeutic effect, the treatment was found to activate the immune system, enhancing the body’s natural response against malignant tumours. This dual-action mechanism is considered particularly promising for improving the effectiveness of cancer therapies while reducing damage to healthy tissues.
Experts note that further research and clinical trials will be required before the technology can be applied in routine medical practice.
This breakthrough builds on other achievements by the BRICS countries in the development of innovative cancer therapies. For example, in India, a team from the Institute of Advanced Study in Science and Technology (IASST) has developed magnetic nanoparticles that use hyperthermia to destroy tumour cells by raising their temperature to around 46°C.
According to IANS, a partner of TV BRICS. This method allows for localised action using external magnetic fields, which reduces side effects and improves the precision of treatment, positioning it as a promising alternative to traditional therapies.
In Egypt, the healthcare system has incorporated new immunotherapy drugs for the treatment of liver cancer, available in at least 22 specialist centres. These units offer free diagnosis, monitoring and treatment on a case-by-case basis and form part of a national programme that also includes early detection via ultrasound and regular screening at dozens of centres, which has enabled the identification of thousands of cases and expanded access to advanced therapies, according to Daily News Egypt, a partner of TV BRICS.
Meanwhile, Iran has developed domestically produced radiopharmaceuticals capable of treating up to 30 types of cancer. These technologies, considered among the most advanced internationally, enable more effective treatments through nuclear medicine. Furthermore, the country is promoting scientific cooperation by proposing the creation of shared laboratory networks among partner countries, with the aim of optimising resources and accelerating research. This is reported by Mehr News Agency, a partner of TV BRICS.
08.06.2612:00 
24 minutes 26 sec.